featured
Inhibition of the KCa2 Potassium Channel in Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
Nat. Med. 2023 Dec 13;[EPub Ahead of Print], AG Holst, J Tomcsányi, B Vestbjerg, M Grunnet, US Sørensen, JG Diness, BH Bentzen, N Edvardsson, SH Hohnloser, DL Bhatt, P DorianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.